Aridis Pharmaceuticals, LLC is a private biologics drug development company using formulation and delivery technologies to provide differentiated, high value products. Our mission is to address important diseases that have a significant impact on life expectancy, such as infectious diseases in children. Our solution lies in producing dried biologicals that are stable at room temperature and administered in “ready-to-use” formats. For example, an oral rotavirus vaccine in a temperature stable, quick dissolving wafer to facilitate vaccine distribution can prevent 500,000 childhood deaths worldwide each year.
